AbbVie, Inc. (ABBV)
261.07
+10.01
(+3.99%)
USD |
NYSE |
Jul 02, 16:00
260.18
-0.89
(-0.34%)
After-Hours: 20:00
AbbVie Price : 261.07 for July 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 02, 2026 | 252.30 | 261.64 | 250.51 | 261.07 | 7.114M |
| Jul 01, 2026 | 250.75 | 251.80 | 247.56 | 251.06 | 6.988M |
| Jun 30, 2026 | 255.00 | 255.50 | 250.10 | 251.64 | 7.000M |
| Jun 29, 2026 | 253.05 | 255.99 | 249.20 | 254.31 | 9.761M |
| Jun 26, 2026 | 245.26 | 253.35 | 244.66 | 253.35 | 52.64M |
| Jun 25, 2026 | 233.66 | 244.61 | 233.66 | 243.14 | 10.28M |
| Jun 24, 2026 | 236.35 | 237.36 | 232.85 | 234.89 | 7.311M |
| Jun 23, 2026 | 232.97 | 235.31 | 231.30 | 234.76 | 7.366M |
| Jun 22, 2026 | 221.94 | 232.32 | 221.94 | 230.01 | 9.913M |
| Jun 18, 2026 | 221.37 | 222.35 | 215.37 | 216.49 | 9.646M |
| Jun 17, 2026 | 222.40 | 222.84 | 218.83 | 221.23 | 5.624M |
| Jun 16, 2026 | 223.31 | 223.50 | 219.15 | 222.47 | 5.946M |
| Jun 15, 2026 | 226.00 | 226.50 | 220.00 | 221.59 | 5.262M |
| Jun 12, 2026 | 227.50 | 228.40 | 224.32 | 227.73 | 4.087M |
| Jun 11, 2026 | 226.01 | 227.55 | 224.04 | 224.77 | 4.569M |
| Jun 10, 2026 | 226.93 | 227.14 | 224.12 | 224.95 | 4.147M |
| Jun 09, 2026 | 224.80 | 227.14 | 221.72 | 225.42 | 4.258M |
| Jun 08, 2026 | 226.75 | 228.58 | 221.16 | 223.07 | 4.916M |
| Jun 05, 2026 | 227.37 | 230.47 | 226.00 | 227.23 | 6.249M |
| Jun 04, 2026 | 222.50 | 224.99 | 219.84 | 224.94 | 6.782M |
| Jun 03, 2026 | 214.81 | 219.54 | 213.72 | 217.13 | 5.668M |
| Jun 02, 2026 | 211.01 | 216.57 | 208.99 | 215.40 | 5.862M |
| Jun 01, 2026 | 215.26 | 216.50 | 211.51 | 212.93 | 4.858M |
| May 29, 2026 | 219.02 | 219.60 | 214.90 | 217.72 | 7.621M |
| May 28, 2026 | 215.90 | 219.38 | 215.90 | 218.63 | 5.191M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 216.12 |
| Gilead Sciences, Inc. | 131.27 |
| Regeneron Pharmaceuticals, Inc. | 654.27 |
| Travere Therapeutics, Inc. | 56.92 |
| Amgen, Inc. | 374.15 |
Price Related Metrics
| PE Ratio | 128.77 |
| PS Ratio | 7.367 |
| Price to Free Cash Flow | 23.16 |
| Earnings Yield | 0.78% |
| Market Cap | 461.24B |
| Operating PE Ratio | 21.94 |
| Normalized PE Ratio | 35.67 |